References
- Chandra P, Brouwer KL. (2004). The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21:719–35
- Hassen AM, Lam D, Chiba M, et al. (1996). Uptake of sulfate conjugates by isolated rat hepatocytes. Drug Metab Disposition 24:792–8
- Hirano M, Maeda K, Shitara Y, Sugiyama Y. (2004). Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans. J Pharmacol Exp Ther 311:139–46
- Jacquemin E, Hagenbuch B, Stieger B, et al. (1994). Expression cloning of a rat liver Na+-independent organic anion transporter. Proc Natl Acad Sci USA 91:133–7
- Jacquez JA. (1996). Compartmental analysis in biology and medicine. Ann Arbor (MI): BioMedware
- Kullak-Ublick GA, Hagenbuch B, Stieger B, et al. (1994). Functional characterization of the basolateral rat liver organic anion transporting polypeptide. Hepatology 20:411–16
- Li AP, Lu C, Brent JA, et al. (1999). Cryopreserved human hepatocytes: characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential. Chem Biol Interact 121:17–35
- Ménochet K, Kenworthy K, Houston JB, Galetin A. (2012). Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model. J Pharmacol Exp Ther 341:2–15
- Murray JD. (2003). Mathematical biology II: spatial models and biomedical applications. 3rd ed. Springer
- Reinoso RF, Telfer BA, Brennan BS, Rowland M. (2001). Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution. Drug Metab Disposition 29:453–9
- Paine SW, Parker AJ, Gardiner P, et al. (2008). Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes. Drug Metab Dispos 36:1365–74
- Petzinger E, Fückel D. (1992). Evidence for a saturable, energy-dependent and carrier-mediated uptake of oral antidiabetics into rat hepatocytes. Eur J Pharmacol 213:381–91
- Poirier A, Lave T, Portmann R, et al. (2008). Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model. Drug Metab Dispos 36:2434–44
- Seglen PO, Prescott DM. (1976). Methods in cell biology. Vol. XIII (Prescott DM, ed.). New York: Academic Press, 29
- Shimada S, Fujino H, Morikawa T, et al. (2003). Uptake mechanism of pitavastatin, a new inhibitior of HMG-CoA reductase, in rat hepatocytes. Drug Metab Pharmacokin 18:245–51
- Shitara Y, Horie T, Sugiyama Y. (2006). Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 27:425–46
- Soars MG, Grime K, Sproston JL, et al. (2007). Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859–65
- Watanabe T, Kusuhara H, Maeda K, et al. (2009). Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of Pitavastatin in humans. J Pharmacol Exp Ther 328:652–62
- Webborn PJ, Parker AJ, Denton RL, Riley RJ. (2007). In vitro–in vivo extrapolation of hepatic clearance involving active uptake: theoretical and experimental aspects. Xenobiotica 37:1090–109